MedTrace Logo

A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension

NCT00965744 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-08-27

No results posted yet for this study

Summary

The aim of this trial was to verify the efficiency of a new surgical device (the LigaSure vessels sealing system) in esophagogastric decongestion and splenectomy in patients with portal hypertension.

Conditions

Interventions

DEVICE

Vessel sealing system LigaSure

Patients in VS group undergoing esophagogastric decongestion (Azygoportal Disconnection) and splenectomy with or without esophageal transaction with the vessel sealing system LigaSure.

Sponsors & Collaborators

  • Shanghai Changzheng Hospital

    lead OTHER

Principal Investigators

  • Qiang Wang, MD · Shanghai Chang Zheng Hospital

  • Jia Dong Gao, MD · Department of General Surgery, Shanghai Chang Zheng Hospital

  • Wei Jun Wang, MD · Department of General Surgery, Shanghai Chang Zheng Hospital

  • Hou Shan Yao, MD · Department of General Surgery, Shanghai Chang Zheng Hospital

  • Zhi Qian Hu, MD · Department of General Surgery, Shanghai Chang Zheng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00965744 on ClinicalTrials.gov